⌘K

Home/Filings/4/0001144204-15-003458

4//SEC Filing

Arch Therapeutics, Inc. 4

Accession 0001144204-15-003458

CIK 0001537561operating

View on SEC.gov Company Profile

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 12:39 PM ET

Size

5.6 KB

Accession

0001144204-15-003458

Insider Transaction Report

Form 4

Period: 2015-01-22

Arch Therapeutics, Inc.ARTH

Norchi Terrence W

DirectorPres, CEO, Sec, and Treas10% Owner

Transactions

Award
Employee Stock Option (right to buy)
2015-01-22+400,000→ 400,000 total
Exercise: $0.19Exp: 2025-01-21→ Common Stock (400,000 underlying)

Footnotes (1)

[F1]Of the Shares subject to the Option, 25% shall vest immediately, 25% shall vest twelve (12) months after the Vesting Commencement Date, and 1/24 of the remaining unvested Shares subject to the Option shall vest on each of the next twenty four (24) monthly anniversaries of the Vesting Commencement Date thereafter.

Documents

1 file

4
v399356_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Arch Therapeutics, Inc.

CIK 0001537561

Entity typeoperating

IncorporatedNV

Related Parties

1

filerCIK 0001537561

Filing Metadata

Form type: 4
Filed: Jan 22, 7:00 PM ET
Accepted: Jan 23, 12:39 PM ET
Size: 5.6 KB

View on SEC.gov